Advertisement
Advertisement
July 5, 2016
Merit Medical Acquires Dfine, Inc.
July 6, 2016—Merit Medical Systems, Inc. announced that it has acquired Dfine, Inc. in a merger transaction through which Dfine has become a wholly owned subsidiary of Merit. The purchase consideration was approximately $97.5 million in cash. Dfine is headquartered in San Jose, California.
According to Merit Medical Systems, Dfine’s products are directed to vertebral augmentation (kyphoplasty and vertebroplasty), as well as targeted radiofrequency ablation of metastatic spinal tumors. Dfine’s product lines have US Food and Drug Administration 510(k) clearance and European CE Mark approval.
The company advised that it plans to combine Merit’s oncology segments, including embolics, microcatheters, and biopsy products, into a newly created interventional oncology and spine division, alongside its cardiovascular and peripheral divisions. Dfine has a presence in Germany and Austria, as well as limited distribution partners. Merit will seek to expand in Australia, Canada, Japan, China, the Nordic countries, and other regions.
Advertisement
Advertisement
